Loading company…
Zentrela develops an EEG device that measures brain activity and assesses cannabis effects.
Founded in 2015 and based in Hamilton, Canada, Zentrela develops Cognalyzer®, an AI-based EEG device designed to measure cannabis effects on the brain. In February 2021, it received USD 0.85 million in Seed funding from Jornic Ventures to commercialize its cannabis impairment test and build a database of product effects.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in